BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 19689234)

  • 1. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.
    Risacher SL; Shen L; West JD; Kim S; McDonald BC; Beckett LA; Harvey DJ; Jack CR; Weiner MW; Saykin AJ;
    Neurobiol Aging; 2010 Aug; 31(8):1401-18. PubMed ID: 20620664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
    Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
    Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.
    Spulber G; Niskanen E; Macdonald S; Kivipelto M; Padilla DF; Julkunen V; Hallikainen M; Vanninen R; Wahlund LO; Soininen H
    Curr Alzheimer Res; 2012 May; 9(4):516-24. PubMed ID: 22191564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Misra C; Fan Y; Davatzikos C
    Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
    Duara R; Loewenstein DA; Potter E; Appel J; Greig MT; Urs R; Shen Q; Raj A; Small B; Barker W; Schofield E; Wu Y; Potter H
    Neurology; 2008 Dec; 71(24):1986-92. PubMed ID: 19064880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Alzheimer's disease using a hypometabolic convergence index.
    Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Bandy D; Alexander GE; Thompson PM; Shaw L; Trojanowski JQ; Jack CR; Landau SM; Foster NL; Harvey DJ; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
    Neuroimage; 2011 May; 56(1):52-60. PubMed ID: 21276856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Egger K; Marksteiner J; Esterhammer R; Hinterhuber H; Deisenhammer EA; Schocke M
    PLoS One; 2014; 9(8):e106062. PubMed ID: 25153085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.
    Leow AD; Yanovsky I; Parikshak N; Hua X; Lee S; Toga AW; Jack CR; Bernstein MA; Britson PJ; Gunter JL; Ward CP; Borowski B; Shaw LM; Trojanowski JQ; Fleisher AS; Harvey D; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Apr; 45(3):645-55. PubMed ID: 19280686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.
    Karas G; Sluimer J; Goekoop R; van der Flier W; Rombouts SA; Vrenken H; Scheltens P; Fox N; Barkhof F
    AJNR Am J Neuroradiol; 2008 May; 29(5):944-9. PubMed ID: 18296551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
    Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
    Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
    Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.